India Ratings and Research (Ind-Ra) opines the 5.0% yoy revenue growth in India's pharmaceutical market (IPM) during October 2021 was due to price increases, as volumes were impacted due to lower COVID-19 product sales and a higher base impact. "Acute
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/31MZD5A
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/31MZD5A